Takeda Inches Closer To Shire Buy With £46B Offer

Japanese drugmaker Takeda gained some ground Tuesday in its pursuit of Dublin-based Shire, with the rare disease-focused biopharmaceutical company revealing it is keen on the early terms of Takeda's sweetened, £46...

Already a subscriber? Click here to view full article